BRAEME SEYMOUR GLAUN
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology BALTIMORE, MD NPI 1154371482
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology MD Biogen, Inc. All categories
General Payments — all program years on this page
$85,904.22
- Category: General Payments
- Program years: PY2018–2024
- Record count: 500
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $6,813.36 across 92 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,041.00 | 2 |
| Food and Beverage | $1,949.05 | 85 |
| Consulting Fee | $562.00 | 3 |
| Travel and Lodging | $261.31 | 2 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Biogen, Inc. | $4,783.23 | 11 |
| EMD Serono, Inc. | $577.71 | 11 |
| ABBVIE INC. | $481.06 | 29 |
| Amgen Inc. | $173.49 | 10 |
| UCB, Inc. | $124.99 | 1 |
| Genentech USA, Inc. | $98.82 | 4 |
| Nevro Corp. | $85.60 | 5 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $64.94 | 3 |
| CSL Behring | $60.60 | 2 |
| Lundbeck LLC | $57.68 | 2 |
| Teva Pharmaceuticals USA, Inc. | $56.99 | 2 |
| PFIZER INC. | $35.00 | 2 |
| Celgene Corporation | $29.86 | 2 |
| Alexion Pharmaceuticals, Inc. | $26.32 | 1 |
| Vanda Pharmaceuticals Inc. | $25.49 | 1 |
| EISAI INC. | $24.30 | 1 |
| REVANCE THERAPEUTICS, INC. | $23.38 | 1 |
| Averitas Pharma Inc. | $22.81 | 1 |
| TG THERAPEUTICS, INC. | $21.67 | 1 |
| SK Life Science, Inc. | $20.51 | 1 |
| Neurelis, Inc. | $18.91 | 1 |
By program year
Records — PY2024 (92)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.